<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02276638</url>
  </required_header>
  <id_info>
    <org_study_id>CEM-530-US-0002</org_study_id>
    <nct_id>NCT02276638</nct_id>
  </id_info>
  <brief_title>Comparative Study of Specular Microscopes for Measurements of Cell Density, Coefficient of Variation and Hexagonality</brief_title>
  <official_title>Comparative Study of the Specular Microscopes for Center Point Method and Corner Point Method for the Measurements of Endothelial Cell Density Measurements, Coefficient of Variation of Endothelial Cell Area and % Hexagonality.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Nidek Co. LTD.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Nidek Co. LTD.</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The primary objective of this clinical study is to collect clinical data to support an FDA
      510(k) submission for the Nidek CEM-530 Center point method and Corner point method. The
      secondary objective is to evaluate any adverse events found during the clinical study.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The primary objective of this clinical study is to collect clinical data to support an FDA
      510(k) submission for the Nidek CEM-530 Center point method and Corner point method.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>September 2014</start_date>
  <completion_date type="Actual">October 2014</completion_date>
  <primary_completion_date type="Actual">October 2014</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Center Method Corneal Endothelial Cell Density</measure>
    <time_frame>single time point - 1 day</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Center Method Coefficient of Variation of Endothelial Cell Area</measure>
    <time_frame>single time point - 1 day</time_frame>
    <description>Coefficient of variation(CV) is that Standard deviation (SD) divided by the average area of endothelial cell analyzed</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Percentage Hexagonality</measure>
    <time_frame>single time point - 1 day</time_frame>
    <description>Percentage hexagonality(%HEX) is that Proportion of hexagonal cells found in the analyzed endothelium</description>
  </primary_outcome>
  <number_of_groups>3</number_of_groups>
  <enrollment type="Actual">79</enrollment>
  <condition>Corneal Endothelial Cell Loss</condition>
  <arm_group>
    <arm_group_label>18-28 years old Non-pathologic</arm_group_label>
    <description>Device: Specular Microscope Nidek CEM-530 Device: Specular Microscope Konan CELLCHEK XL</description>
  </arm_group>
  <arm_group>
    <arm_group_label>29-80 years old Non-pathologic</arm_group_label>
    <description>Device: Specular Microscope Nidek CEM-530 Device: Specular Microscope Konan CELLCHEK XL</description>
  </arm_group>
  <arm_group>
    <arm_group_label>29-80 years old pathological</arm_group_label>
    <description>Device: Specular Microscope Nidek CEM-530 Device: Specular Microscope Konan CELLCHEK XL</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Specular Microscope Nidek CEM-530</intervention_name>
    <description>Nidek CEM-530</description>
    <arm_group_label>18-28 years old Non-pathologic</arm_group_label>
    <arm_group_label>29-80 years old Non-pathologic</arm_group_label>
    <arm_group_label>29-80 years old pathological</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Specular Microscope Konan CELLCHEK XL</intervention_name>
    <description>Konan CELLCHEK XL</description>
    <arm_group_label>18-28 years old Non-pathologic</arm_group_label>
    <arm_group_label>29-80 years old Non-pathologic</arm_group_label>
    <arm_group_label>29-80 years old pathological</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Ophthalmology Practice
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Non-Pathologic: Male or female subjects from 18 to 80 years old who have full legal
             capacity to volunteer on the date the informed consent is signed. Subjects who can
             follow the instructions by the clinical staff at the clinical site,and can attend
             examinations on the scheduled examination date. Subjects who agree to participate in
             the study.

          -  Pathologic: Male and female subjects from 29 to 80 years old who have full legal
             capacity to volunteer on the date the informed consent is signed. Subjects who can
             follow the instructions by the clinical staff at the clinical site, and can attend
             examinations on the scheduled examination date. Subjects who agree to participate in
             the study. At least one eye with any of the following conditions:

               -  History of post-op surgical trauma including bullous keratopathy

               -  History of corneal transplant

               -  Physical injury or trauma to the cornea

               -  Long term Fuch's dystrophy, Guttata or other corneal endothelial dystrophies

               -  Keratoconus

               -  Long term PMMA contact lens use (greater than 3 years)

        Exclusion Criteria:

          -  Non-Pathologic: Male and female subjects from 29 to 80 years old who have full legal
             capacity to volunteer on the date the informed consent is signed. Subjects who can
             follow the instructions by the clinical staff at the clinical site, and can attend
             examinations on the scheduled examination date. Subjects who agree to participate in
             the study. At least one eye with any of the following conditions:

               -  History of post-op surgical trauma including bullous keratopathy

               -  History of corneal transplant

               -  Physical injury or trauma to the cornea

               -  Long term Fuch's dystrophy, Guttata or other corneal endothelial dystrophies

               -  Keratoconus

               -  Long term PMMA contact lens use (greater than 3 years)

          -  Pathologic: History of cataract, refractive or ocular surgical procedures that render
             the cornea opaque or otherwise impact its ability to be imaged using the
             investigational device. Fixation problems which may prevent obtaining at least poor
             quality (refer to Figure 1) CEM-530 and KONAN CELLCHEK PLUS images in either eye.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Gail Torkildsen, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Andover Eye Associates</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Andover Eye Associates</name>
      <address>
        <city>Andover</city>
        <state>Massachusetts</state>
        <zip>01810</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>March 2019</verification_date>
  <study_first_submitted>October 14, 2014</study_first_submitted>
  <study_first_submitted_qc>October 24, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 28, 2014</study_first_posted>
  <results_first_submitted>March 25, 2016</results_first_submitted>
  <results_first_submitted_qc>November 15, 2018</results_first_submitted_qc>
  <results_first_posted type="Actual">March 11, 2019</results_first_posted>
  <last_update_submitted>March 10, 2019</last_update_submitted>
  <last_update_submitted_qc>March 10, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">March 20, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Corneal Endothelial Cell Loss</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>18-28 Years Old Non-pathologic</title>
          <description>18-28 years old Non-pathologic Device: Nidek CEM-530</description>
        </group>
        <group group_id="P2">
          <title>29-80 Years Old Non-pathologic</title>
          <description>29-80 years old Non-pathologic Device: Nidek CEM-530</description>
        </group>
        <group group_id="P3">
          <title>29-80 Years Old Pathological</title>
          <description>29-80 years old pathological Device: Nidek CEM-530</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="28"/>
                <participants group_id="P2" count="28"/>
                <participants group_id="P3" count="23"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="28"/>
                <participants group_id="P2" count="28"/>
                <participants group_id="P3" count="23"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>18-28 Years Old Non-pathologic</title>
          <description>18-28 years old Non-pathologic Device: Nidek CEM-530</description>
        </group>
        <group group_id="B2">
          <title>29-80 Years Old Non-pathologic</title>
          <description>29-80 years old Non-pathologic Device: Nidek CEM-530</description>
        </group>
        <group group_id="B3">
          <title>29-80 Years Old Pathological</title>
          <description>29-80 years old pathological Device: Nidek CEM-530</description>
        </group>
        <group group_id="B4">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="28"/>
            <count group_id="B2" value="28"/>
            <count group_id="B3" value="23"/>
            <count group_id="B4" value="79"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>&lt;=18 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Between 18 and 65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="28"/>
                    <measurement group_id="B2" value="28"/>
                    <measurement group_id="B3" value="23"/>
                    <measurement group_id="B4" value="79"/>
                  </measurement_list>
                </category>
                <category>
                  <title>&gt;=65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="22.2" spread="3.8"/>
                    <measurement group_id="B2" value="53" spread="13.42"/>
                    <measurement group_id="B3" value="63.9" spread="12.39"/>
                    <measurement group_id="B4" value="44.1" spread="20.54"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="13"/>
                    <measurement group_id="B2" value="19"/>
                    <measurement group_id="B3" value="15"/>
                    <measurement group_id="B4" value="47"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="15"/>
                    <measurement group_id="B2" value="9"/>
                    <measurement group_id="B3" value="8"/>
                    <measurement group_id="B4" value="32"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>United States</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="28"/>
                    <measurement group_id="B2" value="28"/>
                    <measurement group_id="B3" value="23"/>
                    <measurement group_id="B4" value="79"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Center Method Corneal Endothelial Cell Density</title>
        <time_frame>single time point - 1 day</time_frame>
        <population>Not all participants indicated in the Participant Flow Module were analysed.</population>
        <group_list>
          <group group_id="O1">
            <title>18-28 Years Old Non-pathologic</title>
            <description>18-28 years old Non-pathologic Device: Nidek CEM-530</description>
          </group>
          <group group_id="O2">
            <title>29-80 Years Old Non-pathologic</title>
            <description>29-80 years old Non-pathologic Device: Nidek CEM-530</description>
          </group>
          <group group_id="O3">
            <title>29-80 Years Old Pathological</title>
            <description>29-80 years old pathological Device: Nidek CEM-530</description>
          </group>
        </group_list>
        <measure>
          <title>Center Method Corneal Endothelial Cell Density</title>
          <population>Not all participants indicated in the Participant Flow Module were analysed.</population>
          <units>cells/mm2</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="28"/>
                <count group_id="O2" value="27"/>
                <count group_id="O3" value="19"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3069.5" spread="346.41"/>
                    <measurement group_id="O2" value="2678.6" spread="391.33"/>
                    <measurement group_id="O3" value="2514" spread="351.02"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Center Method Coefficient of Variation of Endothelial Cell Area</title>
        <description>Coefficient of variation(CV) is that Standard deviation (SD) divided by the average area of endothelial cell analyzed</description>
        <time_frame>single time point - 1 day</time_frame>
        <population>Not all participants indicated in the Participant Flow Module were analysed.</population>
        <group_list>
          <group group_id="O1">
            <title>18-28 Years Old Non-pathologic</title>
            <description>18-28 years old Non-pathologic Device: Nidek CEM-530</description>
          </group>
          <group group_id="O2">
            <title>29-80 Years Old Non-pathologic</title>
            <description>29-80 years old Non-pathologic Device: Nidek CEM-530</description>
          </group>
          <group group_id="O3">
            <title>29-80 Years Old Pathological</title>
            <description>29-80 years old pathological Device: Nidek CEM-530</description>
          </group>
        </group_list>
        <measure>
          <title>Center Method Coefficient of Variation of Endothelial Cell Area</title>
          <description>Coefficient of variation(CV) is that Standard deviation (SD) divided by the average area of endothelial cell analyzed</description>
          <population>Not all participants indicated in the Participant Flow Module were analysed.</population>
          <units>percent of Coefficient of variation</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="28"/>
                <count group_id="O2" value="27"/>
                <count group_id="O3" value="19"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="20.3" spread="1.90"/>
                    <measurement group_id="O2" value="23.3" spread="3.27"/>
                    <measurement group_id="O3" value="23.0" spread="4.11"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Percentage Hexagonality</title>
        <description>Percentage hexagonality(%HEX) is that Proportion of hexagonal cells found in the analyzed endothelium</description>
        <time_frame>single time point - 1 day</time_frame>
        <population>Not all participants indicated in the Participant Flow Module were analysed.</population>
        <group_list>
          <group group_id="O1">
            <title>18-28 Years Old Non-pathologic</title>
            <description>18-28 years old Non-pathologic Device: Nidek CEM-530</description>
          </group>
          <group group_id="O2">
            <title>29-80 Years Old Non-pathologic</title>
            <description>29-80 years old Non-pathologic Device: Nidek CEM-530</description>
          </group>
          <group group_id="O3">
            <title>29-80 Years Old Pathological</title>
            <description>29-80 years old pathological Device: Nidek CEM-530</description>
          </group>
        </group_list>
        <measure>
          <title>Percentage Hexagonality</title>
          <description>Percentage hexagonality(%HEX) is that Proportion of hexagonal cells found in the analyzed endothelium</description>
          <population>Not all participants indicated in the Participant Flow Module were analysed.</population>
          <units>Percentage hexagonality</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="28"/>
                <count group_id="O2" value="27"/>
                <count group_id="O3" value="19"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="63.0" spread="6.33"/>
                    <measurement group_id="O2" value="57.1" spread="6.66"/>
                    <measurement group_id="O3" value="58.7" spread="7.96"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>1 month</time_frame>
      <group_list>
        <group group_id="E1">
          <title>18-28 Years Old Non-pathologic</title>
          <description>Device: Nidek CEM-530 Device: Konan Specular Microscope CELLCHEK XL
Specular Microscope: Nidek CEM-530
Specular Microscope: Konan CELLCHECK XL</description>
        </group>
        <group group_id="E2">
          <title>29-9- Years Old Non-pathologic</title>
          <description>Device: Nidek CEM-530 Device: Konan Specular Microscope CELLCHEK XL
Specular Microscope: Nidek CEM-530
Specular Microscope: Konan CELLCHECK XL</description>
        </group>
        <group group_id="E3">
          <title>29-80 Years Old Pathological</title>
          <description>Device: Nidek CEM-530 Device: Konan Specular Microscope CELLCHEK XL
Specular Microscope: Nidek CEM-530
Specular Microscope: Konan CELLCHECK XL</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="28"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="28"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="23"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="28"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="28"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="23"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Head, Regulatory Affairs</name_or_title>
      <organization>Nidek</organization>
      <phone>(800) 223-9044</phone>
      <email>support@nidek.com</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

